18556196. IL4I1 INHIBITORS AND METHODS OF USE simplified abstract (Merck Sharp & Dohme LLC)

From WikiPatents
Jump to navigation Jump to search

IL4I1 INHIBITORS AND METHODS OF USE

Organization Name

Merck Sharp & Dohme LLC

Inventor(s)

George Madalin Giambasu of Natick MA (US)

Andrew M. Haidle of Somerville MA (US)

Brett A. Hopkins of Brownsburg IN (US)

James P. Jewell of Newton MA (US)

Matthew A. Larsen of Templeton CA (US)

Charles A. Lesburg of Waban MA (US)

Ping Liu of Westfield NJ (US)

Qinglin Pu of Needham MA (US)

Sulagna Sanyal of Belmont MA (US)

Phieng Siliphaivanh of Newton MA (US)

Matthew Tudor of Philadelphia PA (US)

Catherine M. White of Canton MA (US)

Xin Yan of Newton Highlands MA (US)

Lianyun Zhao of Shanghai (CN)

Xiao Mei Zheng of Dover MA (US)

William P. Kaplan of Moseley VA (US)

Michaelyn Claire Lux of Brookline MA (US)

Derun Li of West Roxbury MA (US)

Rebecca Johnson of Oakland CA (US)

IL4I1 INHIBITORS AND METHODS OF USE - A simplified explanation of the abstract

This abstract first appeared for US patent application 18556196 titled 'IL4I1 INHIBITORS AND METHODS OF USE

Simplified Explanation

The invention describes a method for synthesizing benzimidazole derivatives and intermediates using aryl halides and primary amines, with specific additives and catalysts.

  • Proceeding arylation between aryl halide and primary amine
  • Using L-pro as an additive and cuprous iodide as a catalyst
  • Conducting molecular arylation coupling reaction for aryl iodide or aryl bromide and primary amine
  • Starting with iodo phenylamine compound and bromophenylamine compound
  • Synthesizing the material through several-step transformation

Key Features and Innovation

  • Utilizes specific additives and catalysts for efficient synthesis
  • Involves molecular arylation coupling reactions for specific compounds
  • Offers a method for synthesizing benzimidazole derivatives and intermediates

Potential Applications

The method can be used in pharmaceutical research for developing new drugs, as benzimidazole derivatives have various biological activities.

Problems Solved

Provides a streamlined process for synthesizing benzimidazole derivatives and intermediates, potentially reducing time and resources required.

Benefits

  • Efficient and effective method for synthesizing benzimidazole derivatives
  • Potential for discovering new pharmaceutical compounds

Commercial Applications

  • Pharmaceutical industry for drug development
  • Chemical industry for production of specialty compounds

Prior Art

Readers can explore prior research on benzimidazole derivatives and related synthesis methods in academic journals and patent databases.

Frequently Updated Research

Stay updated on advancements in benzimidazole derivative synthesis and related pharmaceutical applications through scientific publications and industry conferences.

Questions about Benzimidazole Derivative Synthesis

What are the key additives and catalysts used in the synthesis process?

The key additives include L-pro, and the catalyst is cuprous iodide.

How can this method benefit the pharmaceutical industry?

This method can streamline the synthesis of benzimidazole derivatives, potentially leading to the discovery of new drugs with various biological activities.


Original Abstract Submitted

The invention discloses a synthesizing method of benzimidazole derivant and intermediate, which is characterized by the following: proceeding arylation among aryl halide and primary amine; adopting L-pro as additive, cuprous iodide as catalyst; proceeding molecular arylation coupling reaction for aryl iodide or aryl bromide and primary amine; adopting iodo phenylamine compound and bromophenylamine compound as starting material; synthesizing the material through several-step transformation.